Spero Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference Transcript
Good day, everybody. Thank you so much for dialing in or joining into the afternoon sessions of Bank of America's Annual Health Care Conference. My name is Jason Gerberry. I cover specialty pharma and small-, mid-cap biotech at Bank of America. And I am pleased to be introducing our next company presenter, Spero Therapeutics. And I'm introducing Ankit Mahadevia, CEO. Spero, for those of you who don't know, is a development stage company with a focus in the anti-infective and antibiotics space. So Ankit has some slides. And so I'm going to turn it over to him. And at the end, I think we have some time for some questions.
So Ankit, all yours.
Thank you, Jason, and to the Bank of America team for the opportunity to share our progress. On Slide 2 are our forward-looking statements. And on Slide 3 -- I'd guide the folks on the webcast, too. And we appreciate the opportunity, Jason. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
